{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:58:54Z","timestamp":1793289534053,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["899163"],"award-info":[{"award-number":["899163"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["899163"],"award-info":[{"award-number":["899163"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["899163"],"award-info":[{"award-number":["899163"]}]},{"name":"Sanquin Research Fund","award":["SRF-YIA-23-06"],"award-info":[{"award-number":["SRF-YIA-23-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94064-4","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T13:51:49Z","timestamp":1743169909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Factor H-related 2 levels dictate FHR dimer composition"],"prefix":"10.1038","volume":"15","author":[{"given":"Bert R. J.","family":"Veuskens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke C.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"van Mierlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Derlagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia C. H.","family":"Keijzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hoogenboezem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taco W.","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"JUN","key":"94064_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle, N. S., Church, S. E., Fremeaux-Bacchi, V. & Roumenina, L. T. Complement system part I\u2014molecular mechanisms of activation and regulation. Front. Immunol. 6(JUN), 1\u201330. https:\/\/doi.org\/10.3389\/fimmu.2015.00262 (2015).","journal-title":"Front. Immunol."},{"issue":"10","key":"94064_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel, P. F. & Skerka, C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9(10), 729\u2013740. https:\/\/doi.org\/10.1038\/nri2620 (2009).","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"94064_CR3","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00018-016-2418-4","volume":"74","author":"R Parente","year":"2017","unstructured":"Parente, R., Clark, S. J., Inforzato, A. & Day, A. J. Complement factor H in host defense and immune evasion. Cell. Mol. Life Sci. 74(9), 1605\u20131624. https:\/\/doi.org\/10.1007\/s00018-016-2418-4 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"94064_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2017.12.018","author":"M J\u00f3zsi","year":"2019","unstructured":"J\u00f3zsi, M., Schneider, A. E., K\u00e1rp\u00e1ti, \u00c9. & S\u00e1ndor, N. Complement factor H family proteins in their non-canonical role as modulators of cellular functions. Semin. Cell Dev. Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2017.12.018 (2019).","journal-title":"Semin. Cell Dev. Biol."},{"issue":"11","key":"94064_CR5","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/OXFORDJOURNALS.MOLBEV.A026270","volume":"17","author":"J Krushkal","year":"2000","unstructured":"Krushkal, J., Bat, O. & Gigli, I. Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. Mol. Biol. Evol. 17(11), 1718\u20131730. https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.MOLBEV.A026270 (2000).","journal-title":"Mol. Biol. Evol."},{"issue":"19","key":"94064_CR6","doi-asserted-by":"publisher","first-page":"E4433","DOI":"10.1073\/pnas.1717600115","volume":"115","author":"S Cantsilieris","year":"2018","unstructured":"Cantsilieris, S. et al. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family. Proc. Natl. Acad. Sci. USA 115(19), E4433\u2013E4442. https:\/\/doi.org\/10.1073\/pnas.1717600115 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"94064_CR7","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1172\/JCI68280","volume":"123","author":"A Tortajada","year":"2013","unstructured":"Tortajada, A. et al. C3 glomerulopathy\u2013associated CFHR1 mutation alters FHR oligomerization and complement regulation. J. Clin. Invest. 123(6), 2434\u20132446. https:\/\/doi.org\/10.1172\/JCI68280 (2013).","journal-title":"J. Clin. Invest."},{"issue":"6","key":"94064_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.it.2015.04.008","volume":"36","author":"M J\u00f3zsi","year":"2015","unstructured":"J\u00f3zsi, M., Tortajada, A., Uzonyi, B., Goicoechea de Jorge, E. & Rodr\u00edguez de C\u00f3rdoba, S. Factor H-related proteins determine complement-activating surfaces. Trends Immunol. 36(6), 374\u2013384. https:\/\/doi.org\/10.1016\/j.it.2015.04.008 (2015).","journal-title":"Trends Immunol."},{"issue":"JUL","key":"94064_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01607","volume":"9","author":"P S\u00e1nchez-Corral","year":"2018","unstructured":"S\u00e1nchez-Corral, P., Pouw, R. B., L\u00f3pez-Trascasa, M. & J\u00f3zsi, M. Self-damage caused by dysregulation of the complement alternative pathway: Relevance of the factor H protein family. Front. Immunol. 9(JUL), 1\u201319. https:\/\/doi.org\/10.3389\/fimmu.2018.01607 (2018).","journal-title":"Front. Immunol."},{"key":"94064_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219260110","author":"E Goicoechea De Jorge","year":"2013","unstructured":"Goicoechea De Jorge, E. et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1219260110 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"94064_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01328","author":"AE van Beek","year":"2017","unstructured":"van Beek, A. E. et al. Factor H-related (FHR)-1 and FHR-2 form homo- and heterodimers, while FHR-5 circulates only as homodimer in human plasma. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.01328 (2017).","journal-title":"Front. Immunol."},{"issue":"1","key":"94064_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4049\/jimmunol.1600483","volume":"199","author":"\u00c1I Csincsi","year":"2017","unstructured":"Csincsi, \u00c1. I. et al. FHR-1 binds to C-reactive protein and enhances rather than inhibits complement activation. J. Immunol. 199(1), 292\u2013303. https:\/\/doi.org\/10.4049\/jimmunol.1600483 (2017).","journal-title":"J. Immunol."},{"issue":"6","key":"94064_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2021101318","volume":"33","author":"B Marquez-Tirado","year":"2022","unstructured":"Marquez-Tirado, B. et al. Factor H-related protein 1 drives disease susceptibility and prognosis in C3 glomerulopathy. J. Am. Soc. Nephrol. 33(6), 1137\u20131153. https:\/\/doi.org\/10.1681\/ASN.2021101318 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"94064_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/J.MOLIMM.2022.08.010","volume":"151","author":"P Banerjee","year":"2022","unstructured":"Banerjee, P. et al. Evaluating the clinical utility of measuring levels of factor H and the related proteins. Mol. Immunol. 151, 166\u2013182. https:\/\/doi.org\/10.1016\/J.MOLIMM.2022.08.010 (2022).","journal-title":"Mol. Immunol."},{"issue":"8","key":"94064_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ajhg.2021.05.015","volume":"108","author":"V Cipriani","year":"2021","unstructured":"Cipriani, V. et al. Beyond factor H: The impact of genetic-risk variants for age-related macular degeneration on circulating factor-H-like 1 and factor-H-related protein concentrations. Am. J. Hum. Genet. 108(8), 1385\u20131400. https:\/\/doi.org\/10.1016\/j.ajhg.2021.05.015 (2021).","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"94064_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/J.AJHG.2021.06.002","volume":"108","author":"L Lor\u00e9s-Motta","year":"2021","unstructured":"Lor\u00e9s-Motta, L. et al. Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration. Am. J. Human Genetics 108(8), 1367\u20131384. https:\/\/doi.org\/10.1016\/J.AJHG.2021.06.002 (2021).","journal-title":"Am. J. Human Genetics"},{"issue":"10","key":"94064_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng1890","volume":"38","author":"AE Hughes","year":"2006","unstructured":"Hughes, A. E. et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genetics 38(10), 1173\u20131177. https:\/\/doi.org\/10.1038\/ng1890 (2006).","journal-title":"Nat. Genetics"},{"issue":"6","key":"94064_CR18","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1167\/iovs.15-18744","volume":"57","author":"AE Hughes","year":"2016","unstructured":"Hughes, A. E. et al. Sequence and expression of complement factor H gene cluster variants and their roles in age-related macular degeneration risk. Invest. Ophthalmol. Vis. Sci. 57(6), 2763\u20132769. https:\/\/doi.org\/10.1167\/iovs.15-18744 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"AUG","key":"94064_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01727","volume":"9","author":"AE van Beek","year":"2018","unstructured":"van Beek, A. E. et al. Reference intervals of factor H and factor H-related proteins in healthy children. Front. Immunol. 9(AUG), 1\u20136. https:\/\/doi.org\/10.3389\/fimmu.2018.01727 (2018).","journal-title":"Front. Immunol."},{"key":"94064_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.876776","author":"AE van Beek","year":"2022","unstructured":"van Beek, A. E. et al. Low levels of factor H family proteins during meningococcal disease indicate systemic processes rather than specific depletion by Neisseria meningitidis. Front. Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2022.876776 (2022).","journal-title":"Front. Immunol."},{"issue":"8","key":"94064_CR21","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ajhg.2021.06.002","volume":"108","author":"L Lor\u00e9s-Motta","year":"2021","unstructured":"Lor\u00e9s-Motta, L. et al. Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration. Am. J. Hum. Genet. 108(8), 1367\u20131384. https:\/\/doi.org\/10.1016\/j.ajhg.2021.06.002 (2021).","journal-title":"Am. J. Hum. Genet."},{"issue":"26","key":"94064_CR22","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1021\/JA203638Y","volume":"133","author":"T Rispens","year":"2011","unstructured":"Rispens, T., Ooijevaar-De Heer, P., Bende, O. & Aalberse, R. C. Mechanism of immunoglobulin G4 Fab-arm exchange. J. Am. Chem. Soc. 133(26), 10302\u201310311. https:\/\/doi.org\/10.1021\/JA203638Y (2011).","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"94064_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1182\/bloodadvances.2018025692","volume":"3","author":"RB Pouw","year":"2019","unstructured":"Pouw, R. B. et al. Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera. Blood Adv. 3(4), 621\u2013632. https:\/\/doi.org\/10.1182\/bloodadvances.2018025692 (2019).","journal-title":"Blood Adv."},{"key":"94064_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00729","author":"RB Pouw","year":"2018","unstructured":"Pouw, R. B. et al. Complement factor H-related protein 4A is the dominant circulating splice variant of CFHR4. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00729 (2018).","journal-title":"Front. Immunol."},{"issue":"3","key":"94064_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0152164","volume":"11","author":"RB Pouw","year":"2016","unstructured":"Pouw, R. B. et al. Complement factor H-related protein 3 serum levels are low compared to factor H and mainly determined by gene copy number variation in CFHR3. PLoS One 11(3), 1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0152164 (2016).","journal-title":"PLoS One"},{"issue":"4","key":"94064_CR26","doi-asserted-by":"publisher","first-page":"e60352","DOI":"10.1371\/JOURNAL.PONE.0060352","volume":"8","author":"LV Holmes","year":"2013","unstructured":"Holmes, L. V. et al. Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32. PLoS One. 8(4), e60352. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0060352 (2013).","journal-title":"PLoS One."},{"issue":"2","key":"94064_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","volume":"115","author":"I Moore","year":"2010","unstructured":"Moore, I. et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 115(2), 379\u2013387. https:\/\/doi.org\/10.1182\/blood-2009-05-221549 (2010).","journal-title":"Blood"},{"issue":"1","key":"94064_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.kint.2023.10.013","volume":"105","author":"L Lucientes-Continente","year":"2024","unstructured":"Lucientes-Continente, L. et al. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)\u2013associated vasculitis. Kidney Int. 105(1), 177\u2013188. https:\/\/doi.org\/10.1016\/j.kint.2023.10.013 (2024).","journal-title":"Kidney Int."},{"issue":"1","key":"94064_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/IMR.13166","volume":"313","author":"L Lucientes-Continente","year":"2023","unstructured":"Lucientes-Continente, L., M\u00e1rquez-Tirado, B. & Goicoechea de Jorge, E. The Factor H protein family: The switchers of the complement alternative pathway. Immunol. Rev. 313(1), 25\u201345. https:\/\/doi.org\/10.1111\/IMR.13166 (2023).","journal-title":"Immunol. Rev."},{"key":"94064_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10766-0","author":"S Irmscher","year":"2019","unstructured":"Irmscher, S. et al. Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-019-10766-0 (2019).","journal-title":"Nat. Commun."},{"issue":"23","key":"94064_CR31","doi-asserted-by":"publisher","first-page":"19528","DOI":"10.1074\/JBC.M112.364471","volume":"287","author":"M Hebecker","year":"2012","unstructured":"Hebecker, M. & J\u00f3zsi, M. Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein. J. Biol. Chem. 287(23), 19528\u201319536. https:\/\/doi.org\/10.1074\/JBC.M112.364471 (2012).","journal-title":"J. Biol. Chem."},{"key":"94064_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.10.029","author":"M Mihlan","year":"2009","unstructured":"Mihlan, M. et al. Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells. Mol. Immunol. https:\/\/doi.org\/10.1016\/j.molimm.2008.10.029 (2009).","journal-title":"Mol. Immunol."},{"issue":"4","key":"94064_CR33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/J.KINT.2017.03.041","volume":"92","author":"A Tortajada","year":"2017","unstructured":"Tortajada, A. et al. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy. Kidney Int. 92(4), 953\u2013963. https:\/\/doi.org\/10.1016\/J.KINT.2017.03.041 (2017).","journal-title":"Kidney Int."},{"key":"94064_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3389\/fimmu.2016.00542","volume":"7","author":"N Sch\u00e4fer","year":"2016","unstructured":"Sch\u00e4fer, N. et al. Complement regulator FHR-3 Is elevated either locally or systemically in a selection of autoimmune diseases. Front. Immunol. 7, 542. https:\/\/doi.org\/10.3389\/fimmu.2016.00542 (2016).","journal-title":"Front. Immunol."},{"issue":"1","key":"94064_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/J.JACI.2016.09.061","volume":"140","author":"TW Kuijpers","year":"2017","unstructured":"Kuijpers, T. W. et al. Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency. J. Allerg. Clin. Immunol. 140(1), 273-277.e10. https:\/\/doi.org\/10.1016\/J.JACI.2016.09.061 (2017).","journal-title":"J. Allerg. Clin. Immunol."},{"issue":"6","key":"94064_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2021101318\/-\/DCSUPPLEMENTAL","volume":"33","author":"B Marquez-Tirado","year":"2022","unstructured":"Marquez-Tirado, B. et al. Factor H-related protein 1 drives disease susceptibility and prognosis in C3 glomerulopathy. J. Am. Soc. Nephrol. 33(6), 1137\u20131153. https:\/\/doi.org\/10.1681\/ASN.2021101318\/-\/DCSUPPLEMENTAL (2022).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"94064_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/J.YMETH.2013.07.018","volume":"65","author":"T Vink","year":"2014","unstructured":"Vink, T., Oudshoorn-Dickmann, M., Roza, M., Reitsma, J. J. & de Jong, R. N. A simple, robust and highly efficient transient expression system for producing antibodies. Methods 65(1), 5\u201310. https:\/\/doi.org\/10.1016\/J.YMETH.2013.07.018 (2014).","journal-title":"Methods"},{"issue":"1\u20132","key":"94064_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/J.JIM.2010.11.010","volume":"365","author":"T Rispens","year":"2011","unstructured":"Rispens, T. et al. Label-free assessment of high-affinity antibody\u2013antigen binding constants. Comparison of bioassay, SPR, and PEIA-ellipsometry. J. Immunol. Methods 365(1\u20132), 50\u201357. https:\/\/doi.org\/10.1016\/J.JIM.2010.11.010 (2011).","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"94064_CR39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0161-5890(88)90169-1","volume":"25","author":"R Hoekzema","year":"1988","unstructured":"Hoekzema, R., Martens, M., Brouwer, M. C. & Hack, C. E. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the \u201carms\u201d of C1q. Mol. Immunol. 25(5), 485\u2013494. https:\/\/doi.org\/10.1016\/0161-5890(88)90169-1 (1988).","journal-title":"Mol. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94064-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94064-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94064-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T13:51:56Z","timestamp":1743169916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94064-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94064"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94064-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MCB, TWK and RBP are co-inventors of patents and patents applications describing potentiating anti-FH antibodies and uses thereof. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"After consultation with the ethical board of Sanquin Research, Amsterdam, The Netherlands, a system was established for obtaining blood samples for scientific research (no approval number available). This volunteer system is organized according to Dutch regulations and according to the Declaration of Helsinki. This volunteer system certifies, among others, that: Blood samples used for scientific studies by researchers of the Sanquin Research department were drawn from healthy, anonymized volunteers with written informed consent; No personal characteristics of the volunteers are registered; The volunteers nor those taking the samples know for what project specific samples are used; Allowed annual sample volume and frequency of donation were established after consultation with Sanquin Medical Secretary. Standard operating procedures are available upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"10669"}}